Five Prime Therapeutics, Inc. Current Assets
Five Prime Therapeutics, Inc. had Current Assets of $292.41 million as of 2020-12-31, per its 10-K filed 2021-03-22.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2021-03-22
- 2020-12-31: Assets, Current $292.41M.
- 2020-09-30: Assets, Current $123.28M.
- 2020-06-30: Assets, Current $134.45M.
- 2020-03-31: Assets, Current $150.29M.
| Period end | Assets, Current |
|---|---|
| 2020-12-31 | $292.41M 10-K · filed 2021-03-22 |
| 2020-09-30 | $123.28M 10-Q · filed 2020-11-03 |
| 2020-06-30 | $134.45M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $150.29M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $166.72M 10-K · filed 2021-03-22 |
| 2019-09-30 | $197.49M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $230.01M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $250.54M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $288.57M 10-K · filed 2020-02-27 |
| 2018-09-30 | $332.86M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $363.02M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $403.04M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $311.19M 10-K · filed 2019-02-26 |
| 2017-09-30 | $333.35M 10-Q · filed 2017-11-06 |
| 2017-06-30 | $363.30M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $399.19M 10-Q · filed 2017-05-05 |
| 2016-12-31 | $440.13M 10-K · filed 2018-02-27 |
| 2016-09-30 | $453.97M 10-Q · filed 2016-11-04 |
| 2016-06-30 | $480.13M 10-Q · filed 2016-08-05 |
| 2016-03-31 | $490.58M 10-Q · filed 2016-05-06 |
| 2015-12-31 | $528.28M 10-K · filed 2017-02-24 |
| 2015-09-30 | $190.53M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $210.71M 10-Q · filed 2015-08-07 |
| 2015-03-31 | $220.33M 10-Q · filed 2015-05-14 |
| 2014-12-31 | $151.26M 10-K · filed 2016-03-11 |
| 2014-09-30 | $131.85M 10-Q · filed 2014-11-12 |
| 2014-06-30 | $142.01M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $150.20M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $77.66M 10-K · filed 2015-03-18 |
| 2013-09-30 | $87.89M 10-Q · filed 2013-11-13 |
| 2012-12-31 | $39.10M 10-K · filed 2014-03-26 |